Serological response to a third dose of SARS-CoV-2 vaccine according to previous infection history.

Saved in:
Bibliographic Details
Title: Serological response to a third dose of SARS-CoV-2 vaccine according to previous infection history.
Authors: Ota K; Department of Laboratory Medicine, Nagasaki University Hospital, Nagasaki, Japan., Murakami S; Abbott Japan LLC, Tokyo, Japan., Ishihara K; Department of Laboratory Medicine, Nagasaki University Hospital, Nagasaki, Japan., Sasaki D; Department of Laboratory Medicine, Nagasaki University Hospital, Nagasaki, Japan., Usui T; Department of Laboratory Medicine, Nagasaki University Hospital, Nagasaki, Japan., Mitsumoto-Kaseida F; Department of Laboratory Medicine, Nagasaki University Hospital, Nagasaki, Japan., Sakamoto K; Department of Laboratory Medicine, Nagasaki University Hospital, Nagasaki, Japan., Kosai K; Department of Laboratory Medicine, Nagasaki University Hospital, Nagasaki, Japan., Hasegawa H; Department of Laboratory Medicine, Nagasaki University Hospital, Nagasaki, Japan., Takazono T; Department of Respiratory Medicine, Nagasaki University Hospital, Nagasaki, Japan., Furumoto A; Juzenkai Hospital, Nagasaki, Japan.; Infectious Diseases Experts Training Center, Nagasaki University Hospital, Nagasaki, Japan., Asoh N; Juzenkai Hospital, Nagasaki, Japan., Yoshimine H; Inoue Hospital, Nagasaki, Japan., Sawai T; Nagasaki Harbor Medical Center, Nagasaki, Japan., Onizuka M; Nagasaki Kita Tokushukai Hospital, Nagasaki, Japan., Makimoto N; Tagami Hospital, Nagasaki, Japan., Izumikawa K; Infection Control and Education Center, Nagasaki University Hospital, Nagasaki, Japan., Mukae H; Department of Respiratory Medicine, Nagasaki University Hospital, Nagasaki, Japan., Kohno S; Nagasaki University, Nagasaki, Japan., Yanagihara K; Department of Laboratory Medicine, Nagasaki University Hospital, Nagasaki, Japan.
Source: Vaccine: X [Vaccine X] 2023 Apr; Vol. 13, pp. 100282. Date of Electronic Publication: 2023 Mar 17.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101748769 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2590-1362 (Electronic) Linking ISSN: 25901362 NLM ISO Abbreviation: Vaccine X Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2590-1362
DOI:10.1016/j.jvacx.2023.100282